1.15TWD
115.78 MTWD
1.68 BTWD
90.12 M
About APEX BIOTECHNOLOGY CORP
Sector
Industry
CEO
Yan Shih Shen
Website
Headquarters
Hsinchu
Founded
1997
ISIN
TW0001733004
FIGI
BBG000BK0YZ9
Apex Biotechnology Corp. engages in the business of research, development, production, manufacturing, and selling biochemical testing instruments and detection strips; and trading relevant products and components. It operates through the following geographical segments: Taiwan, the United States of America, Italy, Austria, China, and Others. The company was founded on December 2, 1997 and is headquartered in Hsinchu, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 1733 is 33.75 TWD — it has decreased by 2.17% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange APEX BIOTECHNOLOGY CORP stocks are traded under the ticker 1733.
APEX BIOTECHNOLOGY CORP is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for APEX BIOTECHNOLOGY CORP has a max estimate of 35.00 TWD and a min estimate of 35.00 TWD.
1733 earnings for the last quarter are 0.28 TWD whereas the estimation was 0.47 TWD which accounts for −40.43% surprise. Estimated earnings for the next quarter are 0.32 TWD. See more details about APEX BIOTECHNOLOGY CORP earnings.
APEX BIOTECHNOLOGY CORP revenue for the last quarter amounts to 542.00 M TWD despite the estimated figure of 573.00 M TWD. In the next quarter revenue is expected to reach 461.00 M TWD.
Yes, you can track APEX BIOTECHNOLOGY CORP financials in yearly and quarterly reports right on TradingView.
Like other stocks, 1733 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APEX BIOTECHNOLOGY CORP stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. APEX BIOTECHNOLOGY CORP EBITDA is 217.43 M TWD, and current EBITDA margin is 12.97%. See more stats in APEX BIOTECHNOLOGY CORP financial statements.